The largest database of trusted experimental protocols

4 protocols using anti wnt1

1

Comprehensive Chromatin Regulatory Network

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies used were: anti-SIX3, anti-H3K4me1, anti-H3K4me2, anti-JAG1, anti-GLI1, anti-ZEB2, anti-ANGPTL4 (Abcam, Hong Kong, China), anti-NCOA3 (BD Biosciences, USA), anti-MTA3, anti-MBD2/3, anti-H3pan-ac (Millipore, Billerica, MD, USA), anti-LSD1, anti-HDAC1, anti-HDAC2, anti-RbAp46/48 (Sigma-Aldrich, St Louis, MO, USA), anti-MTA1, anti-MTA2, and anti-WNT1 (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Human recombinant Wnt1 was purchased from Sigma-Aldrich. Protein A/G Sepharose CL-4B beads were from Amersham Biosciences (Indianapolis, IN, USA) and shRNAs were from GenePharma Co., Ltd (Shanghai, China).
+ Open protocol
+ Expand
2

Protein Extraction and Western Blotting from Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein extraction from tumor tissues using RIPA buffer (Cell Signaling Technology, Inc. Danvers, MA) and western blotting were performed as described previously studies [18 (link), 19 (link)]. The following primary antibodies were used: anti-Wnt-1, anti-β-catenin, anti-c-myc, anti-cyclin D1, anti-MMP-7, anti-axin-2, anti-APC, anti-c-jun, or anti-β-actin antibodies (Santa Cruz Biotechnology, Inc.). The secondary antibodies were corresponding to the type of primary antibody using anti-mouse or anti-rabbit IgG horseradish peroxidase (HRP)-conjugate (1:1,000 dilution, Cell Signaling Technology, Inc.). Protein bands were visualized by the Enhanced Chemiluminescence kit. The quantification of protein bands were measured by FluorChem Imaging Systems (Alpha Innotech). The data were standardized by β-actin.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Wnt1 and CD44 in Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed and paraffin-embedded gastric malignant and nonmalignant tissue sections were incubated with rabbit polyclonal antibody anti-Wnt1 (dilution 1 : 200, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and antibody anti-CD44 (dilution 1 : 200, Santa Cruz Biotechnology) overnight at 4 °C in a humidified container. Detection was determined by non-biotin horseradish peroxidase detection system and DAB substrate (Dako, Carpinteria, CA, USA). Immunostaining was scored by two independent observers. Briefly, five random views of stained sections were chosen and total 100 tumor cells per view were counted for analysis. Expression of Wnt1 or CD44 in less than 10% of tumor cells examined was defined as negative, expression in 10–29% was defined as low expression, 30–60% was defined as moderate expression, and >60% was defined as intense expression.46 (link)
+ Open protocol
+ Expand
4

Western Blot Analysis of Wnt Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed using radioimmunoassay precipitation assay (RAPA) lysis buffer with a proteinase inhibitor. The quantity of approximately 40 µg proteins in the lysates were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene di uoride (PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were incubated with anti-WNT1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), GSK3β (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), β-catenin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and GAPDH (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 12 h at 4 °C and then washed three times for 5 min.
Following horseradish peroxidase-conjugated secondary antibodies were incubated. The blot was visualized by an enhanced chemiluminescence kit (Thermo Fisher Scienti c, Inc., Rockford, IL, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!